ELAN
Elanco Animal Health
NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$22.65
-1.35% today
Updated 2026-10-27
Market cap
$11.76B
P/E ratio
—
P/S ratio
2.34x
EPS (TTM)
$-0.41
Dividend yield
—
52W range
$19 – $28
Volume
5.1M
Elanco Animal Health (ELAN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$22.65
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$19.75
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.8B | $4.4B | $4.4B | $4.4B | $4.7B | $5.1B | $5.5B | $5.9B | $6.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 7.57% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -3.96%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.